Propranolol Hydrochloride Injection
Brand names: Propranolol, Propranolol Hydrochloride
Category: Cardiovascular
FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Oct 31, 2023 (in shortage 2 years 11 months) · 2 manufacturers, 2 listed presentations
As of Sep 18, 2026, the FDA lists Propranolol Hydrochloride Injection as currently in shortage. Of 2 manufacturer presentations, 1 Unavailable, 1 Available.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10) NDC 0143-9872-10 |
Hikma Pharmaceuticals USA, Inc. | Unavailable | Estimated recovery: TBD |
| Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01) NDC 63323-604-01 |
Fresenius Kabi USA, LLC | Available | Check wholesalers for inventory |
Related medications in shortage
Other Cardiovascular medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Propranolol Hydrochloride Injection (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Propranolol Hydrochloride Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/propranolol-hydrochloride-injection.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).